Hyperbaric Oxygen Therapy for Chronic Fatigue Syndrome (CFS)
ConditionChronic Fatigue Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssaf-Harofeh Medical Center
About this trial
This study evaluates the effects of hyperbaric oxygen therapy (HBOT) in patients with mild to moderate CFS/ME. Participants will undergo 60 HBOT sessions over 3 months with a 3-month follow-up, including physical, cognitive, imaging, and laboratory assessments.
Eligibility criteria
Qualifiers
Subject willing and able to read, understand and sign an informed consent
Diagnosis of mild to moderate severity of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Patients diagnosed with CFS for more than 1 years
Stable psychological and pharmacological treatment for more than three months prior to inclusion
Disqualifiers
Inability to attend scheduled clinic visits and/or comply with the study protocol
Severe and very severe cases of ME/CFS
History or diagnosis of, brain tumors, brain surgery, epilepsy, neurodegenerative diseases
Active malignancy
Trial design
Treatments tested in this trial
- Hyperbaric oxygen therapy
- SHAM treatment
Treatment groups
74 Participants
are divided into 2 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh) Status unavailable 70300, Zrifin
Israel
IsraelSponsors and collaborators
Source ClinicalTrials.gov